A gene transcription signature of obesity in breast cancer

Breast Cancer Research and Treatment

Volumn 132, Issue 3, 2012, Pages 993-1000

  Creighton, Chad J ^a   Sada, Yvonne H ^a   Zhang, Yiqun ^a   Tsimelzon, Anna ^a   Wong, Helen ^b   Dave, Bhuvanesh ^b   Landis, Melissa D ^b   Bear, Harry D ^c   Rodriguez, Angel ^a   Chang, Jenny C ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BMI; Breast cancer; Gene expression profiling; IGF; Insulin like growth factor; Obesity

Indexed keywords

17ALPHA ESTRADIOL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HEXESTROL; LEVONORGESTREL; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C; ESTROGEN RECEPTOR; TUMOR MARKER;

17BETA ESTRADIOL GENE; ARTICLE; BODY MASS; BREAST CANCER; CONTROLLED STUDY; ESTROGEN RECEPTOR 1 GENE; FEMALE; GENE EXPRESSION PROFILING; GENE MAPPING; GENETIC TRANSCRIPTION; HUMAN; IN VITRO STUDY; INSULIN LIKE GROWTH FACTOR 1 GENE; MAJOR CLINICAL STUDY; METASTASIS; MITOGEN ACTIVATED PROTEIN KINASE GENE; NEGRO; OBESITY; ONCOGENE; PHOSPHATIDYLINOSITOL 3 KINASE GENE; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEPTOR GENE; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TUMOR GENE; BREAST TUMOR; DISEASE FREE SURVIVAL; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MORTALITY; NONPARAMETRIC TEST; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; REFERENCE VALUE;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KAPLAN-MEIER ESTIMATE; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; REFERENCE VALUES; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84865194273     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1595-y     Document Type: Article

References (29)

1. WHO Expert Committee (1995) Physical status: the use and interpretation of anthropometry (WHO technical report series no. 854). World Health Organization, Geneva
2. de Onis M, Habicht J (1996) Anthropometric reference data for international use: recommendations from a World Health Organization Expert Committee. Am J Clin Nutr 64:650-658
3. Bernstein L, Ross R (1993) Endogenous hormones and breast cancer risk. Epidemiol Rev 15:48-65
4. Jones B, Kasi S, Curnen M, Owens P, Dubrow R (1997) Severe obesity as an explanatory factor for the black/white difference in stage at diagnosis of breast cancer. Am J Epidemiol 146(5):394-404
5. Dirat B, Bochet L, Escourrou G, Valet P, Muller C (2010) Unraveling the obesity and breast cancer links: a role for cancer-associated adipocytes? Endocr Dev 19:45-52
6. Dawood S, Broglio K, Gonzalez-Angulo A, Kau S, Islam R, Hortobagyi G, Cristofanilli M (2008) Prognostic value of body mass index in locally advanced breast cancer. Clin Cancer Res 14(6):1718-1725
7. McTiernan A, Irwin M, Vongruenigen V (2010) Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol 28(26):4074-4080
8. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406(6797):747-752
9. van de Vijver MJ, He YD, Van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009
10. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu J (2005) Gene-expression profiles to predict distant metastasis of lymphnode-negative primary breast cancer. Lancet 365:671-679
11. Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt AM, Gillet C, Ellis P, Harris A, Bergh J, Foekens JA, Klijn JGM, Larsimont D, Buyse M, Bontempi G, Delorenzi M, Piccart MJ, Sotiriou C (2007) Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol 25(10):1239-1246
12. Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, Haibe-Kains B, Viale G, Delorenzi M, Zhang Y, d'Assignies M, Bergh J, Lidereau R, Ellis P, Harris A, Klijn J, Foekens J, Cardoso F, Piccart M, Buyse M, Sotiriou C (2007) TRANSBIG-Consortium, strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 13(11):3207-3214
13. Hoadley K, Weigman V, Fan C, Sawyer L, He X, Troester M, Sartor C, Rieger-House T, Bernard P, Carey L, Perou C (2007) EGFR associated expression profiles vary with breast tumor subtype. BMC Genomics 8(1):258
14. Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, Pawitan Y, Hall P, Klaar S, Liu ET, Bergh J (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 102(38):13550-13555. doi:10.1073/pnas.0506230102
15. Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, Elledge R, Mohsin S, Osborne CK, Chamness GC, Allred DC, O'Connell P (2003) Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 362(9381):362-369
16. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100:9440-9445
17. Saldanha AJ (2004) Java treeview-extensible visualization of microarray data. Bioinformatics 20:3246-3248
18. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868
19. Creighton C, Nagaraja A, Hanash S, Matzuk M, Gunaratne P (2008) A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions. RNA 14(11):2290-2296
20. Creighton C, Casa A, Lazard Z, Huang S, Tsimelzon A, Hilsenbeck S, Osborne C, Lee A (2008) Insulin-like growth factor I (IGF-I) activates gene transcription programs strongly associated with poor breast cancer prognosis. J Clin Oncol 26(25):4078-4085
21. Calle E, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579-591
22. Creighton C, Fu X, Hennessy B, Casa A, Zhang Y, Gonzalez-Angulo A, Lluch A, Gray J, Brown P, Hilsenbeck S, Osborne C, Mills G, Lee A, Schiff R (2010) Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER?breast cancer. Breast Cancer Res 12(3):R40
23. Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D (2006) Activation of mitogen-activated protein kinase in estrogen receptor {alpha}-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor {alpha}-negative human breast tumors. Cancer Res 66(7):3903-3911
24. Creighton CJ, Cordero KE, Larios JM, Miller RS, Johnson MD, Chinnaiyan AM, Lippman ME, Rae JM (2006) Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors. Genome Biol 7(4):R28
25. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet J-P, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR (2006) The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313(5795):1929-1935. doi:10.1126/science.1132939
26. Pinheiro R, Sarian L, Pinto-Neto A, Morais S, Costa-Paiva L (2009) Relationship between body mass index, waist circumference and waist to hip ratio and the steroid hormone receptor status in breast carcinoma of pre-and postmenopausal women. Breast Cancer Res 18(1):8-12
27. Renehan A, Frystyk J, Flyvbjerg A (2006) Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 17(8):328-336
28. Wang G, Volkow N, Fowler J (2002) The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Targets 6(5):601-609
29. Maresca A, Supuran C (2008) Muscarinic acetylcholine receptors as therapeutic targets for obesity. Expert Opin Ther Targets 12(9):1167-1175